CAMK2D expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.439600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.901200E-01
Normal-vs-Stage2
6.477600E-01
Normal-vs-Stage3
6.249800E-01
Normal-vs-Stage4
1.348800E-01
Stage1-vs-Stage2
8.334600E-01
Stage1-vs-Stage3
3.184600E-01
Stage1-vs-Stage4
3.051200E-01
Stage2-vs-Stage3
3.183600E-01
Stage2-vs-Stage4
1.426840E-01
Stage3-vs-Stage4
5.216000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.524000E-01
Normal-vs-AfricanAmerican
5.733800E-01
Normal-vs-Asian
9.365600E-01
Caucasian-vs-AfricanAmerican
8.539400E-01
Caucasian-vs-Asian
4.655800E-01
AfricanAmerican-vs-Asian
4.606200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.992400E-01
Normal-vs-Female
7.151800E-01
Male-vs-Female
2.798000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.619800E-01
Normal-vs-Age(41-60Yrs)
4.005800E-01
Normal-vs-Age(61-80Yrs)
7.544400E-01
Normal-vs-Age(81-100Yrs)
7.617600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.587400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.670800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.740600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.131630E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.552200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.764600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.772000E-01
Normal-vs-Daily Drinker
8.921400E-01
Normal-vs-Weekly Drinker
9.194800E-01
Normal-vs-Occasional Drinker
5.563000E-01
Normal-vs-Social Drinker
6.377400E-01
Non Drinker-vs-Daily Drinker
9.781800E-01
Non Drinker-vs-Weekly Drinker
9.518200E-01
Non Drinker-vs-Occasional Drinker
3.394000E-01
Non Drinker-vs-Social Drinker
4.264800E-01
Daily Drinker-vs-Weekly Drinker
9.436200E-01
Daily Drinker-vs-Occasional Drinker
4.404200E-01
Daily Drinker-vs-Social Drinker
4.454200E-01
Weekly Drinker-vs-Occasional Drinker
4.271400E-01
Weekly Drinker-vs-Social Drinker
4.616200E-01
Occasional Drinker-vs-Social Drinker
8.812800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.236200E-01
Normal-vs-Grade 2
1.328160E-01
Normal-vs-Grade 3
2.175800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.379000E-01
Grade 1-vs-Grade 3
7.893800E-01
Grade 1-vs-Grade 4
3.236200E-01
Grade 2-vs-Grade 3
7.540000E-01
Grade 2-vs-Grade 4
1.328160E-01
Grade 3-vs-Grade 4
2.175800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.875800E-01
Normal-vs-NonDiabetic
7.535400E-01
Diabetic-vs-NonDiabetic
9.953000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.194400E-01
Normal-vs-NoPancreatitis
7.194000E-01
Pancreatitis-vs-NoPancreatitis
6.507600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.505200E-01
Normal-vs-N1
6.649400E-01
N0-vs-N1
3.866800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.681800E-01
Normal-vs-TP53-NonMutant
5.044200E-01
TP53-Mutant-vs-TP53-NonMutant
7.494100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
